Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00214_DB00554_nanopub.RA2vJvkrfdPpFHnXAPKvm6uTKCLNplfJ4X7VaH5yZKb1Y#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00214_DB00554 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00214_DB00554 label "DDI between Torasemide and Piroxicam - Piroxicam, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Piroxicam is initiated, discontinued or dose changed. [drugbank_resource:DB00214_DB00554]" assertion.
- drugbank_resource:DB00214_DB00554 identifier "drugbank_resource:DB00214_DB00554" assertion.
- drugbank_resource:DB00214_DB00554 title "DDI between Torasemide and Piroxicam - Piroxicam, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Piroxicam is initiated, discontinued or dose changed." assertion.
- drugbank:DB00214 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00214_DB00554 assertion.
- drugbank:DB00554 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00214_DB00554 assertion.